Evotec is a global, publicly listed biotechnology company with more than 2,700 employees at 13 sites, our headquarters are located in Hamburg. We do research on innovative approaches to drug discovery and development for and with leading pharmaceutical and biotechnology companies and academic institutions. By assembling top-class scientists, state-of-the-art technologies as well as substantial experience and expertise in key therapeutic areas including neuroscience, diabetes and complications of diabetes, pain and inflammation, oncology and infectious diseases, Evotec has established a unique leading position.